Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study.
Merimsky O, Meller I, Flusser G, Kollender Y, Issakov J, Weil-Ben-Arush M, Fenig E, Neuman G, Sapir D, Ariad S, Inbar M.
Merimsky O, et al. Among authors: issakov j.
Cancer Chemother Pharmacol. 2000;45(2):177-81. doi: 10.1007/s002800050027.
Cancer Chemother Pharmacol. 2000.
PMID: 10663634
Clinical Trial.